Avience Biomedicals (NSE:AVIENCE) ROE % Adjusted to Book Value: 0.00% (As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals ROE % Adjusted to Book Value?

Avience Biomedicals NSE:AVIENCE 5 ROE % Adjusted to Book Value is 0.00% as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Avience Biomedicals's ROE % for the quarter that ended in Jan. 2026 was 0.00%. Avience Biomedicals's PB Ratio for the quarter that ended in Jan. 2026 was N/A. Avience Biomedicals's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2026 was N/A.

Avience Biomedicals ROE % Adjusted to Book Value Related Terms

Avience Biomedicals ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals ROE % Adjusted to Book Value Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
ROE % Adjusted to Book Value
0.00 0.00 0.00

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
ROE % Adjusted to Book Value 0.00 0.00 0.00 0.00

NSE:AVIENCE vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Avience Biomedicals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avience Biomedicals ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avience Biomedicals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Avience Biomedicals's ROE % Adjusted to Book Value falls into.


NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals ROE % Adjusted to Book Value Calculation

Avience Biomedicals's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=49.90% / N/A
=N/A

Avience Biomedicals's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Avience Biomedicals (NSE:AVIENCE) has a ROE % Adjusted to Book Value of 0.00% as of Jan. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' ROE % Adjusted to Book Value too high?
Avience Biomedicals' current ROE % Adjusted to Book Value is 0.00%. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' ROE % Adjusted to Book Value compare to ABT and SYK?
Avience Biomedicals' ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current ROE % Adjusted to Book Value is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price